-
Plogosertib by Cyclacel Pharmaceuticals for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
25 Dec 2023 18:41 GMT
… is based on genomic technology.
Cyclacel Pharmaceuticals overview
Cyclacel Pharmaceuticals (Cyclacel) is a biopharmaceutical … future-proof advantage over your competitors.
Be better informed
GlobalData, the …
-
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q2 2023 Earnings Call Transcript
11 Aug 2023 17:54 GMT
… thus far. Of notes, a competitor recently disclosed that after a … ;A Session Follow Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) Follow Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC … remarks, we had actually two competitors who seem to have lost …
-
Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q1 2022 Results - Earnings Call Transcript
12 May 2022 03:14 GMT
… , and welcome to the Cyclacel Pharmaceuticals First Quarter 2022 Results Conference … not been matched by other competitors in the transcriptional CDK inhibitor … Operator This does conclude the Cyclacel Pharmaceuticals first quarter 2022 results conference …
-
Xerostomia therapeutics global market 2024 to reach $2.65 billion by 2028 at rate of 5.4%
26 Jun 2024 14:05 GMT
… ., Mission Pharmacal Company, Dentaid Ltd., Cyclacel Pharmaceuticals Inc., Parnell Pharmaceuticals Holdings Ltd … iv bags market major players, competitors'; revenues, market positioning, and …
-
Acute Respiratory Distress Syndrome (ARDS) - Market Insight, Epidemiology and Market Forecast 2022-2032 - ResearchAndMarkets.com
23 Feb 2022 14:32 GMT
… the research and development activities
Competitors Profile
Ache Laboratorios Farmaceuticos
Alexion … Therapeutics Corp.
Cerecor Inc.
Chimerix
Cyclacel Pharmaceuticals
CytoDyn
Diffusion Pharmaceuticals Inc.; University …
-
Infinity Pharmaceuticals Appoints Robert Ilaria, Jr., M.D., as Chief Medical Officer and Brian Schwartz, M.D., to Its Board of Directors
07 Sep 2021 19:13 GMT
… of Mereo Biopharma, Enlivex and Cyclacel pharmaceuticals and an advisor in different … agents by Infinity's competitors for diseases in which Infinity …
-
Infinity Pharmaceuticals Appoints Robert Ilaria, Jr., M.D., as Chief Medical Officer and Brian Schwartz, M.D., to Its Board of Directors
07 Sep 2021 11:35 GMT
… of Mereo Biopharma, Enlivex and Cyclacel pharmaceuticals and an advisor in different … agents by Infinity's competitors for diseases in which Infinity …
-
Cyclin Dependent Kinase 7 Industry Latest Update with Technological Advancement, Emerging Trends, Business Opportunity and Forecast to 2026
08 Dec 2020 05:52 GMT
… Technologies Ltd
● Beta Pharma Inc
● Cyclacel Pharmaceuticals Inc
● Qurient Co Ltd
● Syros … and an edge over the competitors. Industry Research is the credible …
-
Neuroblastoma Drug Market Forecasts by MacroGenics, Inc, Advaxis, Amgen Inc, AstraZeneca, Bristol-Myers Squibb Company
28 Oct 2020 23:08 GMT
… 2026
Few of the major competitors currently working in the global … , Pfizer Inc, Pierre Fabre Group, Cyclacel Pharmaceuticals, Inc, BioDiem and others.
Get …
-
Cyclin Dependent Kinase 9 Market : Facts, Figures and Analytical Insights 2020-2026
15 Jul 2020 07:47 GMT
… Inc, AstraZeneca Plc, Bayer AG, Cyclacel Pharmaceuticals Inc, Eli Lilly and Company … regional growth of the leading competitors operating in the market on …
About
© 1995-2025